Meij, P.

( P. Meij)

response patient t-cell ebv-specific ebv reactivation peptide epitope reactivation pp 65 protein recipient blood ebv-lpd number donor study month hla-a 2 transplantation hla-a hla-b speci monitoring recovery hla-b 7 time point transplant figure 1000 geq /ml virus lytic result epstein-barr 6 months panel analysis graft cell transplantation table tetramer lymphocytes marrow epstein-barr virus 3 months individual sample disease value range virol ebv-specific t cells allogeneic point level heart sct recipients lymphoproliferative ifn-g t-celldepleted cytokine speci ﬁc responses ebv load 15- aa peptides cd 8 t-cells t-celldepleted sct development allograft heart transplant recipients bone marrow transplant cmv-speci ﬁc t-cells *0201 kern f cytomegaloviru 10.1002/ measurement mhc-mm sct donor peptide pools berlin *3501

2 Most Recent Publications

Dissection of the CMV specific T-cell response is required for optimized cardiac transplant monitoring (Article)
Kirchner, A. Hoffmeister, B. Lehmkuhl, H.B. Volkmer-Engert, R. Volk, H.D. Gratama, J-W. Kern, F. Cherepnev-G, G. Fuhrmann, S. Streitz, M. Lachmann, R.A. Bunde, T. Meij, P. Schönemann, C. Hetzer, R.

2008-09-01

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease (Article)
Meij, P. Löwenberg, B. Leiner, I. Pamer, E. Gratama, J-W. Cornelissen, J.J. Esser, J.W.J. van Niesters, H.G.M. Baarle, D. van Miedema, F. Blake, N. Rickinson, A.B.

2003-01-01

Message*:
Your Email Adress*:
	*: Required fields, please provide an email address so that the RePub team can contact you if needed.